Pathological cardiac hypertrophy is associated with nearly all forms of heart failure. It
develops in response to disorders such as coronary artery disease, hypertension and …

Thyroid hormones (THs) play an essential role in the maintenance of cardiovascular
homeostasis and are involved in the modulation of cardiac contractility, heart rate, diastolic …

Cardiac hypertrophy, which is characterized by the enlargement of cell size, reactivation of
fetal genes, remains one of the most important triggers to heart failure. Increasing evidence …

Hyperthyroidism is associated with cardiac hypertrophy, fibrosis, and increased risk of
cardiovascular mortality. Sacubitril/valsartan (LCZ696) is a new combined drug that has …

Cardiac hypertrophy is the most documented cardiomyopathy following hyperthyroidism in
experimental animals. Thyroid hormone‐induced cardiac hypertrophy is described as a …

The cardiac growth process (hypertrophy) is a crucial phenomenon conserved across a
wide array of species and is critically involved in the maintenance of cardiac homeostasis …

In previous works we demonstrated an inverse correlation between plasma Coenzyme Q10
(CoQ10) and thyroid hormones; in fact, CoQ10 levels in hyperthyroid patients were found …

Thyroid hormones (THs) play a pivotal role in cardiac homeostasis. TH imbalances alter
cardiac performance and ultimately cause cardiac dysfunction. Although short-term …

Myocardial infarction leads to a reduction in nitric oxide (NO) bioavailability and an increase
in reactive oxygen species (ROS) levels. This scenario has been shown to be detrimental to …

Clinical studies have shown a correlation between thyroid disorders and cardiac diseases.
High levels of triiodothyronine (T3) induce cardiac hypertrophy, a risk factor for cardiac …